Advertisement
Advertisement
Afinitor安妥

Afinitor Caution For Usage

everolimus

Manufacturer:

Novartis

Distributor:

Zuellig
/
Four Star
Full Prescribing Info
Caution For Usage
Incompatibilities: Not applicable.
Special precautions for disposal and other handling: Important information for caregivers: The extent of absorption of everolimus through topical exposure is not known. Therefore caregivers are advised to avoid contact with the suspension. Hands should be washed thoroughly before and after preparation of the suspension.
Disposal: Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Instructions for use and handling (Dispersible tablet only): Using an oral syringe: The prescribed dose of Afinitor dispersible tablets should be placed in a 10 ml oral dosing syringe graduated in 1 ml increments. A total of 10 mg of Afinitor dispersible tablets per syringe using a maximum of 5 dispersible tablets must not be exceeded. If a higher dose or number of tablets is required, an additional syringe must be prepared. The dispersible tablets must not be broken or crushed. Approximately 5 ml of water and 4 ml of air should be drawn into the syringe. The filled syringe should be placed into a container (with the tip pointing up) for 3 minutes, until the Afinitor dispersible tablets are in suspension. The syringe should be gently inverted 5 times immediately prior to administration. After administration of the prepared suspension, approximately 5 ml of water and 4 ml of air should be drawn into the same syringe, and the contents should be swirled to suspend remaining particles. The entire contents of the syringe should be administered.
Using a small glass: The prescribed dose of Afinitor dispersible tablets should be placed in a small glass (maximum size 100 ml) containing approximately 25 ml of water. A total of 10 mg of Afinitor dispersible tablets per glass using a maximum of 5 dispersible tablets must not be exceeded. If a higher dose or number of tablets is required, an additional glass must be prepared. The dispersible tablets must not be broken or crushed. Three minutes must be allowed for suspension to occur. The contents should be gently stirred with a spoon and then administered immediately. After administration of the prepared suspension, 25 ml of water should be added and be stirred with the same spoon to re-suspend any remaining particles. The entire contents of the glass should be administered.
A complete set of instructions for use is provided at "Instructions for use" under Patient Counselling Information.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement